vaayaa Inclusive Education
Micro-Diploma

Pharmaceutical Manufacturing Processes

5-Year Access Self-Paced Learning Certificate Included

Unlock Full Course

Get instant access to all sections and earn your verified certificate.

$9.99

Table of Contents

FREE PREVIEW — Section 1 of Module 1

Drug Classification and Dosage Form Fundamentals

Drug Classification and Dosage Form Fundamentals

Pharmaceutical manufacturing begins with a clear understanding of how drugs are classified and how those classifications determine the manufacturing approach. Drugs are broadly categorized as small molecules (also called conventional or chemical entities) and biologics (including proteins, monoclonal antibodies, vaccines, and gene therapies). Each category presents distinct manufacturing challenges, regulatory pathways, and quality requirements.

Small molecule drugs are typically synthesized through chemical reactions and processed into solid, liquid, or semi-solid dosage forms. Biologics, by contrast, are produced using living cells or organisms and require highly controlled biological manufacturing environments. Understanding which category a drug belongs to is the first step in determining its production pathway.

Dosage forms define how a drug is delivered to the patient and how it releases its active ingredient. The most common categories include:

  • Solid dosage forms: Tablets, capsules, granules, and powders — the most widely manufactured forms due to their stability and ease of administration.
  • Liquid dosage forms: Solutions, suspensions, emulsions, and syrups — used when rapid absorption or patient swallowability is a priority.
  • Semi-solid dosage forms: Creams, ointments, gels, and lotions — designed for topical or transdermal delivery.
  • Sterile dosage forms: Injections, ophthalmic preparations, and inhalation products — requiring the highest level of manufacturing controls due to the risk of contamination.

Each dosage form requires specific equipment, process conditions, and testing protocols. A tablet manufacturing line is fundamentally different from a sterile injectable fill-finish operation. Recognizing these differences helps manufacturers allocate resources, design facilities, and write appropriate procedures.

The route of administration also drives formulation decisions. Oral drugs must survive the gastrointestinal environment and achieve systemic absorption, while injectable drugs must be sterile, pyrogen-free, and within acceptable pH and osmolality ranges. These requirements cascade directly into manufacturing specifications.

Note: The choice of dosage form is not arbitrary — it is driven by the drug's physicochemical properties, therapeutic intent, patient population, and stability profile. Manufacturers must respect these design decisions throughout every stage of production.
Example

Consider a mid-size pharmaceutical company developing a pain management product. Their active ingredient is highly soluble in water but degrades rapidly in light. Based on these properties, the formulation team selects an oral tablet with an opaque film coat rather than a clear liquid syrup. The manufacturing team must then design a granulation and compression process that preserves stability, while the packaging team specifies amber or opaque blister packaging. Every downstream manufacturing decision traces back to the initial dosage form selection.

Quick Revision
  • Drugs are classified as small molecules or biologics, each with distinct manufacturing requirements.
  • Dosage forms include solid, liquid, semi-solid, and sterile categories.
  • Route of administration directly influences formulation and manufacturing specifications.
  • Dosage form selection is driven by physicochemical properties, stability, and patient need.
  • Understanding dosage form fundamentals is essential before entering any manufacturing operation.

Like what you see? Unlock the full course to continue.

Limited Offer
$9.99
Limited Offer $9.99